...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Evolution of Carbapenem-Resistant Acinetobacter baumannii Revealed through Whole-Genome Sequencing and Comparative Genomic Analysis
【24h】

Evolution of Carbapenem-Resistant Acinetobacter baumannii Revealed through Whole-Genome Sequencing and Comparative Genomic Analysis

机译:通过全基因组测序和比较基因组分析揭示了耐碳青霉烯的鲍曼不动杆菌的进化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Acinetobacter baumannii is a globally important nosocomial pathogen characterized by an evolving multidrug resistance. A total of 35 representative clinical A. baumannii strains isolated from 13 hospitals in nine cities in China from 1999 to 2011, including 32 carbapenem-resistant and 3 carbapenem-susceptible A. baumannii strains, were selected for whole-genome sequencing and comparative genomic analysis. Phylogenetic analysis revealed that the earliest strain, strain 1999BJAB11, and two strains isolated in Zhejiang Province in 2004 were the founder strains of carbapenem-resistant A. baumannii. Ten types of AbaR resistance islands were identified, and a previously unreported AbaR island, which comprised a two-component response regulator, resistance-related proteins, and RND efflux system proteins, was identified in two strains isolated in Zhejiang in 2004. Multiple transposons or insertion sequences (ISs) existed in each strain, and these gradually tended to diversify with evolution. Some of these IS elements or transposons were the first to be reported, and most of them were mainly found in strains from two provinces. Genome feature analysis illustrated diversified resistance genes, surface polysaccharides, and a restriction-modification system, even in strains that were phylogenetically and epidemiologically very closely related. IS-mediated deletions were identified in the type VI secretion system region, the csuE region, and core lipooligosaccharide (LOS) loci. Recombination occurred in the heme utilization region, and intrinsic resistance genes (blaADC and blaOXA-51-like variants) and three novel blaOXA-51-like variants (blaOXA-424, blaOXA-425, and blaOXA-426) were identified. Our results could improve the understanding of the evolutionary processes that contribute to the emergence of carbapenem-resistant A. baumannii strains and help elucidate the molecular evolutionary mechanism in A. baumannii.
机译:鲍曼不动杆菌是全球重要的医院病原体,其特征是不断发展的多药耐药性。从1999年至2011年,从中国9个城市的13家医院中分离出的35例代表性鲍曼不动杆菌临床菌株,包括32株耐碳青霉烯耐药性和3株对碳青霉烯敏感的鲍曼不动杆菌进行了全基因组测序和比较基因组分析。系统进化分析表明,最早的菌株1999BJAB11和2004年在浙江省分离出的两个菌株是耐碳青霉烯的鲍曼不动杆菌的始祖菌株。鉴定出十种类型的AbaR耐药岛,并于2004年在浙江分离出的两个菌株中鉴定了一个以前未报告的AbaR岛,该岛包含两组分响应调节剂,耐药相关蛋白和RND外排系统蛋白。每个菌株中都存在插入序列(IS),并且它们随着进化而逐渐趋于多样化。其中一些IS元素或转座子是第一个被报道的,其中大多数主要发现于两个省的菌株中。基因组特征分析表明,即使在系统发育和流行病学上密切相关的菌株中,抗性基因,表面多糖和限制性修饰系统的多样性也很丰富。 IS介导的删除被确定在VI型分泌系统区域,csuE区域和核心脂寡糖(LOS)基因座。重组发生在血红素利用区域,并鉴定出内在抗性基因(blaADC和blaOXA-51样变体)和三个新型blaOXA-51样变体(blaOXA-424,blaOXA-425和blaOXA-426)。我们的结果可以增进对进化过程的理解,这些进化过程有助于耐碳青霉烯的鲍曼不动杆菌菌株的出现,并有助于阐明鲍曼不动杆菌的分子进化机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号